Showing results (351-360 of 537) with videos related to

Sort By:
Pageof 54
Preventive Medicine|February 20, 2003
An academic detailing intervention to disseminate physician-delivered smoking cessation counseling: smoking cessation outcomes of the Physicians Counseling Smokers ProjectMichael G Goldstein, Raymond Niaura, Cynthia Willey, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1975
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cellsG Goldstein, M Scheid, U Hammerling, et al.
Biological Psychiatry|July 29, 2000
Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depressionG Goldstein, M Fava, M Culler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1981
Functional analysis of human T cell subsets defined by monoclonal antibodies. III. Regulation of helper factor production by T cell subsetsY Thomas, J Sosman, L Rogozinski, et al.
Diagnostic Immunology|January 1, 1983
Classification of human lymphocytes and monocytes with the OK series of monoclonal antibodiesM A Talle, N Allegar, M Makowski, et al.
Diagnostic Immunology|January 1, 1983
Resting and activation antigens of T cells: studies with OKT10 and OKT20 monoclonal antibodiesR S Mittler, R Look, B Sheffler, et al.
The Journal of Rheumatology|August 1, 1984
Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studiesE M Veys, H Mielants, G Verbruggen, et al.
Lancet (London, England)|December 6, 1980
Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosisG Routhier, O Epstein, G Janossy, et al.
European Journal of Medical Research|January 30, 2008
Body composition and bone metabolism in young Gaucher disease type I patients treated with imigluceraseMuriel S Parisi, S R Mastaglia, A Bagur, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2008
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanomaOliver G Goldstein, Laela M Hajiaghamohseni, Shereen Amria, et al.
Pageof 54